Demo
Close Language Tab
Locate us
Languages
Z
Zenith Drugs Ltd Pharmaceuticals
₹ 67.55 -1.45 (-2.10%)
  • NSE
  • BSE

Overview

  • BSE Code 92356
  • NSE Symbol ZENITHDRUG
  • ISIN Demat INE0QWN01013
  • Book Value (₹)
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.)
  • P/E (TTM)
  • EPS (TTM)
  • Div Yield (%)

Performance

Today’s Low 65.75
Today’s High 69.00

67.55
52W Low 47.15
52W High 154.40

67.55
Open 69.00
Prev. Close 69.00
Volume 11,200.00

Corporate Actions

Zenith Drugs Limited - Updates
Apr 17, 2025

'Zenith Drugs Limited has informed the Exchange regarding Cancellation of Board Meeting dated April 17, 2025.'.

About Zenith Drugs Ltd

Zenith Drugs Ltd was initially formed on November 15, 2000 as a Private Limited Company in the name of 'Zenith Drugs Private Limited' as registered with the Registrar of Companies, in the State of Madhya Pradesh, Gwalior. Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior.

Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore. With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients. the Company is mainly involved in manufacturing and Trading of Medicines. It offers a wide range of formulations in various forms such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.

the Company was established in 2000 by the visionary founders, Late Shri Ramniklal Soni, and Mr. Mukesh Jain. Initially in 2001, Company started as a modest manufacturing house for oral and external formulations. However, recognizing the importance of quality and compliance, the Company swiftly shifted to a Schedule M GMP compliant unit in 2004 where it started the production of two lines which are liquid orals and ointments. In 2007, it expanded the product line by incorporating ORS Powder manufacturing into their operations. In 2016, the Company established present manufacturing facility, which holds WHO GMP certification. In 2019, it expanded the product line by introducing liquid externals and capsules.

the Company propose Initial Public Fresh Issue upto 42,92,000 Equity Shares.

Founded: 2000
Managing Director: Sandeep Bhardwaj
Address: K # 72/5 Village Muradpura, NA Depalpur, Indore, Madhya Pradesh, 453001,